BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12717198)

  • 1. Use of older controlled non-heart-beating donors for liver transplantation.
    Fukumori T; Kato T; Levi D; Olson L; Nishida S; Ganz S; Nakamura N; Madariaga J; Ohkohchi N; Satomi S; Miller J; Tzakis A
    Transplantation; 2003 Apr; 75(8):1171-4. PubMed ID: 12717198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor age and outcome of liver transplantation.
    Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
    Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation from controlled non-heart-beating donors.
    D'alessandro AM; Hoffmann RM; Knechtle SJ; Odorico JS; Becker YT; Musat A; Pirsch JD; Sollinger HW; Kalayoglu M
    Surgery; 2000 Oct; 128(4):579-88. PubMed ID: 11015091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
    Lee KW; Simpkins CE; Montgomery RA; Locke JE; Segev DL; Maley WR
    Transplantation; 2006 Dec; 82(12):1683-8. PubMed ID: 17198260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cumulative effects of cold ischemic time and older donor age on liver graft survival.
    Cassuto JR; Patel SA; Tsoulfas G; Orloff MS; Abt PL
    J Surg Res; 2008 Jul; 148(1):38-44. PubMed ID: 18570929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilization of pancreas donors.
    Krieger NR; Odorico JS; Heisey DM; D'Alessandro AM; Knechtle SJ; Pirsch JD; Sollinger HW
    Transplantation; 2003 Apr; 75(8):1271-6. PubMed ID: 12717215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience.
    Kaczmarek B; Manas MD; Jaques BC; Talbot D
    Transplant Proc; 2007 Nov; 39(9):2793-5. PubMed ID: 18021989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of other organs recovered during in situ split-liver procurements.
    Ramcharan T; Glessing B; Lake JR; Payne WD; Humar A
    Liver Transpl; 2001 Oct; 7(10):853-7. PubMed ID: 11679982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced donor age alone does not affect patient or graft survival after liver transplantation.
    Anderson CD; Vachharajani N; Doyle M; Lowell JA; Wellen JR; Shenoy S; Lisker-Melman M; Korenblat K; Crippin J; Chapman WC
    J Am Coll Surg; 2008 Dec; 207(6):847-52. PubMed ID: 19183530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
    Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical variables of donors and recipients with respect to short-term graft outcome in human liver transplantation.
    Totsuka E; Fung U; Hakamada K; Tanaka M; Takahashi K; Nakai M; Morohashi S; Nishimura A; Ishizawa Y; Ono H; Toyoki Y; Narumi S; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2215-8. PubMed ID: 15561195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older liver graft transplantation, cholestasis and synthetic graft function.
    Borchert D; Glanemann M; Mogl M; Langrehr JM; Neuhaus P
    Transpl Int; 2005 Jun; 18(6):709-15. PubMed ID: 15910298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation.
    Moore DE; Feurer ID; Speroff T; Gorden DL; Wright JK; Chari RS; Pinson CW
    Arch Surg; 2005 Mar; 140(3):273-7. PubMed ID: 15781792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and long-term results using older kidneys from cadaver or living donors.
    Berardinelli L; Beretta C; Raiteri M; Carini M
    Clin Transpl; 2001; ():157-66. PubMed ID: 12211778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival.
    Reese PP; Sonawane SB; Thomasson A; Yeh H; Markmann JF
    Transplantation; 2008 Jun; 85(12):1737-44. PubMed ID: 18580465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
    Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation from Maastricht category 2 non-heart-beating donors.
    Otero A; Gómez-Gutiérrez M; Suárez F; Arnal F; Fernández-García A; Aguirrezabalaga J; García-Buitrón J; Alvarez J; Máñez R
    Transplantation; 2003 Oct; 76(7):1068-73. PubMed ID: 14557754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of kidney transplants from non-heart-beating deceased donors as reported to the Japan Organ Transplant Network from April 1995-December 2003: a multi-center report.
    Teraoka S; Nomoto K; Kikuchi K; Hirano T; Satomi S; Hasegawa A; Uchida K; Akiyama T; Tanaka S; Babazona T; Shindo K; Nakamura N
    Clin Transpl; 2004; ():91-102. PubMed ID: 16704141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.